Precision Medicine

In this episode, host Shikha Jain, MD, speaks with Melody Harris about the evolution of precision medicine, what physicians and companies can do to help patients better understand precision oncology and more.

A recent investigation into the molecular roots of systemic lupus erythematosus may point the way toward a new generation of therapeutic targets, according to the researchers.

Despite the incidence of endometrial cancer diagnosis increasing annually, several promising approaches for treatment and diagnosis of endometrial cancer have been approved or are in development.

Chimeric antigen receptor T-cell therapy and precision medicine will highlight the agenda at the 40th annual Congress of Clinical Rheumatology West, set for Sept. 26 to Sept. 29 in San Diego, California.

Lower levels of S100 proteins at baseline predict better treatment response with abatacept in patients with polyarticular-course juvenile idiopathic arthritis, according to data published in Arthritis Research & Therapy.

Healio spoke to Ashley Haggerty, MD, a board certified, fellowship-trained gynecologic oncologist at Hackensack Meridian Medical Group about racial disparities in endometrial cancer.

Healio spoke to Ashley Haggerty, MD, a board certified, fellowship-trained gynecologic oncologist at Hackensack Meridian Medical Group about recent advancements in endometrial cancer care.

In this video, Alexander Chehrazi-Raffle, MD, discusses the results of a study into the use of new precision medicine therapies in prostate cancer, presented at ASCO Annual Meeting.

Topline results from the phase 2b RELIEF trial demonstrate that licaminlimab has the potential to reshape the treatment paradigm of dry eye disease, offering a more precise strategy than current methods.